Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research through Evaluation for Large Language Model in Patient-Clinician Communications.

Research square·2026
Same author

Exploring new frontiers: Outcomes and feasibility of a third radiotherapy course in recurrent prostate cancer.

Tumori·2026
Same author

Defining the combinatorial nature of gene modules in prostate cancer underlying lineage plasticity and metastasis.

Research square·2026
Same author

Cost-effectiveness of vorasidenib in treatment of isocitrate dehydrogenase-mutated low-grade glioma.

Cancer·2026
Same author

Novelty to necessity: large language models in clinical practice-a call to action for physicians.

Internal and emergency medicine·2026
Same author

Unlocking the Potential of AI and Big Data in Cancer Research: Advances and Applications.

Cancers·2026
Same journal

Artificial Intelligence (AI)-Based Computer-Assisted Detection and Diagnosis for Mammography: An Evidence-Based Review of Food and Drug Administration (FDA)-Cleared Tools for Screening Digital Breast Tomosynthesis (DBT).

AI in precision oncology·2025
See all related articles

Related Experiment Video

Updated: Jun 18, 2026

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer
08:54

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

Retrieval-Augmented Generation in Oncology: Promises, Pitfalls, and Early Applications.

Nikhil G Thaker1,2, Wei Liu3, Mark Waddle4

  • 1Bayta Systems, Newtown, Pennsylvania, USA.

AI in Precision Oncology
|June 17, 2026
PubMed
Summary
This summary is machine-generated.

Retrieval-augmented generation (RAG) enhances large language models (LLMs) by grounding them in current data, improving accuracy in oncology. This approach aids clinical decision-making but requires careful implementation and oversight for safe adoption.

Keywords:
decision supportethical and regulatory issues in AImachine learning in researchtreatment planning

More Related Videos

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

Related Experiment Videos

Last Updated: Jun 18, 2026

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer
08:54

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

Area of Science:

  • Artificial Intelligence in Medicine
  • Oncology Informatics
  • Natural Language Processing

Background:

  • Large language models (LLMs) require factual grounding, especially in high-stakes fields like oncology.
  • Retrieval-augmented generation (RAG) integrates external knowledge to improve LLM accuracy and reduce hallucinations.
  • Oncology data is dynamic, necessitating systems that incorporate the latest research and guidelines.

Purpose of the Study:

  • To review the technical aspects of RAG systems.
  • To examine current and emerging applications of RAG in oncology.
  • To analyze the challenges and limitations of RAG in healthcare settings.

Main Methods:

  • Synthesis of RAG architecture and components.
  • Review of current oncology applications (e.g., decision support, patient education, diagnostics).
  • Analysis of emerging RAG developments (e.g., multimodal RAG, explainability).

Main Results:

  • RAG improves treatment recommendations and diagnostic accuracy by integrating evidence.
  • Emerging developments include multimodal RAG and enhanced explainability tools.
  • Challenges include computational costs, retrieval errors, and ethical considerations.

Conclusions:

  • RAG shows significant promise for augmenting oncologists' expertise with timely, evidence-based knowledge.
  • Careful implementation, curated knowledge bases, and human oversight are essential for clinical adoption.
  • RAG can enhance precision medicine and clinical decision support in oncology.